Quarterly Balance Sheet

STELLA PHARMA CORPORATION - Filing #7299803

Concept As at
2024-09-30
As at
2024-03-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,552,792,000 JPY
2,052,704,000 JPY
Securities
200,097,000 JPY
300,943,000 JPY
Work in process
955,646,000 JPY
1,012,691,000 JPY
Raw materials and supplies
2,917,000 JPY
2,988,000 JPY
Other
5,457,000 JPY
42,525,000 JPY
Current assets
5,013,438,000 JPY
3,629,291,000 JPY
Non-current assets
Property, plant and equipment
70,385,000 JPY
81,527,000 JPY
Property, plant and equipment
Buildings
Buildings, net
5,268,000 JPY
5,705,000 JPY
Machinery and equipment
Machinery and equipment, net
57,997,000 JPY
67,863,000 JPY
Tools, furniture and fixtures
Tools, furniture and fixtures, net
7,119,000 JPY
7,958,000 JPY
Intangible assets
53,058,000 JPY
52,548,000 JPY
Intangible assets
Patent right
44,999,000 JPY
47,780,000 JPY
Trademark right
420,000 JPY
487,000 JPY
Software
7,638,000 JPY
4,280,000 JPY
Investments and other assets
68,302,000 JPY
57,255,000 JPY
Investments and other assets
Long-term prepaid expenses
50,130,000 JPY
38,532,000 JPY
Other
18,172,000 JPY
18,722,000 JPY
Non-current assets
191,746,000 JPY
191,330,000 JPY
Assets
5,205,185,000 JPY
3,820,622,000 JPY
Liabilities
Current liabilities
Income taxes payable
9,921,000 JPY
9,980,000 JPY
Current liabilities
219,676,000 JPY
455,599,000 JPY
Non-current liabilities
Long-term borrowings
693,288,000 JPY
773,292,000 JPY
Non-current liabilities
1,905,932,000 JPY
988,010,000 JPY
Liabilities
2,125,609,000 JPY
1,443,610,000 JPY
Net assets
Shareholders' equity
Share capital
2,859,218,000 JPY
2,938,110,000 JPY
Capital surplus
489,135,000 JPY
195,722,000 JPY
Retained earnings
-268,720,000 JPY
-763,749,000 JPY
Treasury shares
-56,000 JPY
-30,000 JPY
Shareholders' equity
3,079,576,000 JPY
2,370,053,000 JPY
Share acquisition rights
JPY
6,959,000 JPY
Net assets
3,079,576,000 JPY
2,377,012,000 JPY
Liabilities and net assets
5,205,185,000 JPY
3,820,622,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.